STOCK TITAN

Exact Sciences schedules third quarter 2022 earnings call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) announced the release of its third quarter 2022 financial results, scheduled for November 3, 2022, after U.S. market close. Management will discuss the results and business updates during a webcast at 5 p.m. ET the same day. Investors can access the live webcast through the company's website. Exact Sciences focuses on cancer screening and diagnostics, leveraging products like Cologuard® and Oncotype®. Further information can be found on their official site.

Positive
  • None.
Negative
  • None.

MADISON, Wis., Oct. 10, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2022 financial results after the close of the U.S. financial markets on November 3, 2022. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

Third quarter 2022 webcast & conference call details

Date:         

Thursday, November 3, 2022

Time:           

5 p.m. ET

Webcast:     

The live webcast can be accessed at www.exactsciences.com

Telephone:     

Domestic callers, dial 888-330-2384


International callers, dial +1 240-789-2701


Access code for both domestic and international callers: 4437608

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-770-2030 domestically or +1 647-362-9199 internationally. The access code for the replay of the call is 4437608. The webcast, conference call, and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com 
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-third-quarter-2022-earnings-call-301644408.html

SOURCE Exact Sciences Corporation

FAQ

What date will Exact Sciences release their third quarter 2022 earnings results?

Exact Sciences will release their third quarter 2022 earnings results on November 3, 2022.

What time is the Exact Sciences Q3 2022 earnings call scheduled?

The earnings call for Exact Sciences is scheduled for 5 p.m. ET on November 3, 2022.

Where can I access the webcast for Exact Sciences' third quarter earnings call?

The webcast for Exact Sciences' third quarter earnings call can be accessed on their official website.

What is Exact Sciences known for?

Exact Sciences is known for providing cancer screening and diagnostic tests, including Cologuard® and Oncotype®.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.16B
182.40M
1.01%
100.86%
7.6%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON